CRP genetic polymorphism is associated with lymph node metastasis in thoracic esophageal squamous cell cancer

Annals of Surgical Oncology

Volumn 16, Issue 9, 2009, Pages 2479-2485

  Motoyama, Satoru ^a   Miura, Masatomo ^b   Hinai, Yudai ^b   Maruyama, Kiyotomi ^a   Usami, Shuetsu ^a   Saito, Hajime ^a   Minamiya, Yoshihiro ^a   Satoh, Shigeru ^a   Murata, Katsuyuki ^a   Suzuki, Toshio ^b   Ogawa, Jun Ichi ^a  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b AKITA UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DNA EXTRACTION; ECHOGRAPHY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE;

AGED; C-REACTIVE PROTEIN; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-2; INTERLEUKIN-4; INTERLEUKIN-6; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RECEPTORS, INTERLEUKIN-10; RECEPTORS, INTERLEUKIN-6; SURVIVAL RATE; THORACIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 68949214358     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0525-2     Document Type: Article

References (49)

1. MB Orringer B Marshall AC Chang J Lee A Pickens CL Lau 2007 Two thousand transhiatal esophagectomies: changing trends, lessons learned Ann Surg. 246 363 72
2. JR Siewert HJ Stein M Feith BL Bruecher H Bartels U Fink 2001 Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1, 000 consecutive resections at a single center in the Western world Ann Surg. 234 360 7
3. C Mariette G Piessen N Briez JP Triboulet 2008 The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent Ann Surg. 247 365 71
4. BP Wijnhoven KT Tran A Esterman BL Bruecher H Bartels U Fink 2007 An evaluation of prognostic factors and tumor staging of resected carcinoma of the esophagus Ann Surg. 245 717 25
5. PW Chiu KF Chan YT Lee JJ Sung JY Lau EK Ng 2008 Endoscopic submucosal dissection used for treating early neoplasia of the foregut using a combination of knives Surg Endosc. 22 777 83
6. L Marnell C Mold TW Du Clos 2005 C-reactive protein: ligands, receptors and role in inflammation Clin Immunol. 117 104 11
7. JS Fleming CR Beaugié I Haviv G Chenevix-Trench OL Tan 2006 Incessant ovulation, inflammation and epithelial ovarian carcinogenesis: revisiting old hypotheses Mol Cell Endocrinol. 247 4 21
8. JR Jackson MP Seed CH Kircher DA Willoughby JD Winkler 1997 The codependence of angiogenesis and chronic inflammation FASEB J. 11 457 65
9. KJ Helzlsouer TP Erlinger EA Platz 2006 C-reactive protein levels and subsequent cancer outcomes: results from a prospective cohort study Eur J Cancer. 42 704 7
10. F Balkwill A Mantovani 2001 Inflammation and cancer: back to Virchow? Lancet. 357 539 45
11. RL Elliott GC Blobe 2005 Role of transforming growth factor Beta in human cancer J Clin Oncol. 23 78 93
12. MH Mangi AC Newland 1999 Interleukin-3 in hematology and oncology: current state of knowledge and future directions Cytokines Cell Mol Ther. 5 87 95
13. TP Erlinger EA Platz N Rifai KJ Helzlsouer 2004 C-reactive protein and the risk of incident colorectal cancer JAMA. 291 585 590
14. H Shimada Y Nabeya S Okazumi H Matsubara T Shiratori T Aoki et al 2003 Elevation of preoperative serum C-reactive protein level is related to poor prognosis in esophageal squamous cell carcinoma J Surg Oncol. 83 248 52
15. K Hashimoto Y Ikeda D Korenaga et al 2005 The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma Cancer. 103 1856 64
16. Y Miyata S Koga M Nishikido et al 2001 Predictive values of acute phase reactants, basic fetoprotein, and immunosuppressive acidic protein for staging and survival in renal cell carcinoma Urology. 58 161 4
17. LA Hefler N Concin G Hofstetter et al 2008 Serum C-reactive protein as independent prognostic variable in patients with ovarian cancer Clin Cancer Res. 14 710 4
18. CS Carlson SF Aldred PK Lee et al 2005 Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels Am J Hum Genet. 77 64 7
19. AJ Szalai J Wu EM Lange MA McCrory CD Langefeld A Williams 2005 Single-nucleotide polymorphisms in the C-reactive protein (CRP) gene promoter that affect transcription factor binding, alter transcriptional activity, and associate with differences in baseline serum CRP level J Mol Med. 83 440 7
20. S Motoyama K Ishiyama K Maruyama et al 2007 Preoperative mapping of lymphatic drainage from the tumor using ferumoxide-enhanced magnetic resonance imaging in clinical submucosal thoracic squamous cell esophageal cancer Surgery. 141 736 47
21. JK Wolford JD Gruber VM Ossowski et al 2003 A C-reactive protein promoter polymorphism is associated with type 2 diabetes mellitus in Pima Indians Mol Genet Metab. 78 136 44
22. AI Russell DS Cunninghame Graham et al 2004 Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus Hum Mol Genet. 13 137 47
23. C Eklund M Kivimäki MS Islam et al 2008 C-reactive protein genetics is associated with carotid artery compliance in men in The Cardiovascular Risk in Young Finns Study Atherosclerosis. 196 841 8
24. CP Day J Grove AK Daly MW Stewart PJ Avery M Walker 1998 Tumour necrosis factor-alpha gene promoter polymorphism and decreased insulin resistance Diabetologia. 41 430 4
25. T Skoog FM van't Hooft B Kallin et al 1999 A common functional polymorphism (C->A substitution at position -863) in the promoter region of the tumour necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha Hum Mol Genet. 8 1443 9
26. TG Kim HY Kim SH Lee et al 1996 Systemic lupus erythematosus with nephritis is strongly associated with the TNFB*2 homozygote in the Korean population Hum Immunol. 46 10 7
27. V Pravica C Perrey A Stevens JH Lee IV Hutchinson 2000 A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production Hum Immunol. 61 863 6
28. XO Shu YT Gao Q Cai et al 2004 Genetic polymorphisms in the TGF-beta 1 gene and breast cancer survival: a report from the Shanghai Breast Cancer Study Cancer Res. 64 836 9
29. F Graziano A Ruzzo D Santini et al 2005 Prognostic role of interleukin-1beta gene and interleukin-1 receptor antagonist gene polymorphisms in patients with advanced gastric cancer J Clin Oncol. 23 2339 45
30. T Lehtimäki R Laaksonen T Janatuinen et al 2003 Interleukin-1B genotype modulates the improvement of coronary artery reactivity by lipid-lowering therapy with pravastatin: a placebo-controlled positron emission tomography study in young healthy men Pharmacogenetics. 13 633 9
31. F Graziano A Ruzzo D Santini et al 2005 Prognostic role of interleukin-1beta gene and interleukin-1 receptor antagonist gene polymorphisms in patients with advanced gastric cancer J Clin Oncol. 23 2339 2345
32. OA Ross MD Curran A Meenagh et al 2003 Study of age-association with cytokine gene polymorphisms in an aged Irish population Mech Ageing Dev. 124 199 206
33. E Noguchi M Shibasaki T Arinami et al 1998 Association of asthma and the interleukin-4 promoter gene in Japanese Clin Exp Allergy. 28 449 453
34. M Buraczynska L Jozwiak P Ksiazek E Borowicz P Mierzicki 2007 Interleukin-6 gene polymorphism and faster progression to end-stage renal failure in chronic glomerulonephritis Transl Res. 150 101 105
35. JK Wolford PB Colligan JD Gruber C Bogardus 2003 Variants in the interleukin 6 receptor gene are associated with obesity in Pima Indians Mol Genet Metab. 80 338 343
36. CJ Edwards-Smith JR Jonsson DM Purdie A Bansal C Shorthouse EE Powell 1999 Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa Hepatology. 30 526 530
37. MA Hall E McGlinn G Coakley et al 2000 Genetic polymorphism of IL-12 p40 gene in immune-mediated disease Genes Immun. 1 219 224
38. LM Coussens Z Werb 2002 Inflammation and cancer Nature. 420 860 867
39. J Vakkila MT Lotze 2004 Inflammation and necrosis promote tumour growth Nat Rev Immunol. 4 641 648
40. HJ Zeh 3rd MT Lotze 2005 Addicted to death: invasive cancer and the immune response to unscheduled cell death J Immunother. 28 1 9
41. D Hanahan RA Weinberg 2000 The hallmarks of cancer Cell. 100 57 70
42. L Marnell C Mold TW Du Clos 2005 C-reactive protein: ligands, receptors and role in inflammation Clin Immunol. 117 104 111
43. LA Lange CS Carlson LA Hindorff et al 2006 Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events JAMA. 296 2703 2711
44. DT Miller RY Zee J Suk Danik et al 2005 Association of common CRP gene variants with CRP levels and cardiovascular events Ann Hum Genet. 69 623 638
45. C Siemes LE Visser JW Coebergh et al 2006 C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study J Clin Oncol. 24 5216 5222
46. W Wen Q Cai YB Xiang et al 2008 The modifying effect of C-reactive protein gene polymorphisms on the association between central obesity and endometrial cancer risk Cancer. 112 2409 2416
47. IS Ockene CE Matthews N Rifai PM Ridker G Reed E Stanek 2001 Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults Clin Chem. 47 444 450
48. HW Wang SF Sui 2001 Dissociation and subunit rearrangement of membrane-bound human C-reactive proteins Biochem Biophys Res Commun. 288 75 79
49. C Marsik R Sunder-Plassmann B Jilma et al 2006 The C-reactive protein (+)1444C/T alteration modulates the inflammation and coagulation response in human endotoxemia Clin Chem. 52 1952 1957